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Aims Medin is a common amyloidogenic protein in humans that accumulates in arteries with advanced age and has been
implicated in vascular degeneration. Medin’s effect on endothelial function remains unknown. The aims are to assess
15 medin’s effects on human arteriole endothelial function and identify potential mechanisms underlying medin-
induced vascular injury.
....................................................................................................................................................................................................
Methods
and results
20 Ex vivo human adipose and leptomeningeal arterioles were exposed (1 h) to medin (0.1, 1, or 5 mM) without or
with FPS–ZM1 [100 mM, receptor for advanced glycation endproducts (RAGE)-specific inhibitor] and endothelium-
dependent function (acetylcholine dilator response) and endothelium-independent function (dilator response to
nitric oxide donor diethylenetriamine NONOate) were compared with baseline control. Human umbilical vein
endothelial cells were exposed to medin without or with FPS–ZM1 and oxidative and nitrative stress, cell viability,
25 and pro-inflammatory signaling measures were obtained. Medin caused impaired endothelial function (vs. baseline
response: -45.2 ± 5.1 and -35.8 ± 7.9% in adipose and leptomeningeal arterioles, respectively, each P< 0.05). Dilator
response to NONOate was not significantly changed. Medin decreased arteriole and endothelial cell nitric oxide
production, increased superoxide production, reduced endothelial cell viability, proliferation, and migration. Medin
increased gene and protein expression of interleukin-6 and interleukin-8 via activation of nuclear factor kappa-light-
30 chain-enhancer of activated B cells (NFjB). Medin-induced endothelial dysfunction and oxidative stress were
reversed by antioxidant polyethylene glycol superoxide dismutase and by RAGE inhibitor FPS-ZM1.
....................................................................................................................................................................................................
Conclusions Medin causes human microvascular endothelial dysfunction through oxidative and nitrative stress and promotes
35 pro-inflammatory signaling in endothelial cells. These effects appear to be mediated via RAGE. The findings repre-
sent a potential novel mechanism of vascular injury.
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1. Introduction
Medin is an amyloidogenic peptide that accumulates with aging in various
arterial beds, being found in all 18 patients studied that were 57 years or
older1 and reported to be present in 97% of a cohort of Caucasian sub-
45 jects above 50 years of age.2 Despite this ubiquity, little is known about
the physiologic or pathologic effects of medin. Medin is a 50 amino acid
peptide derived from milk fat globule protein epidermal growth factor 8
(MFG-E8).1,3,4 It is amyloidogenic and forms vascular amyloid in the aorta
and arteries of the upper part of the body, including intracranial vessels.1
50Prefibrillar medin was shown to induce aortic smooth muscle death
in vitro while increasing the production of matrix–-metalloproteinase-2,3
suggesting a possible link between medin and aortic wall degeneration.
We showed in a preliminary study that human endothelial cell cultures
* Corresponding author. Tel: 602 277 5551, fax: 602 212 2047, E-mail: raymond.migrino@va.gov
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exposed acutely to medin demonstrated oxidative stress and reduced
nitric oxide (NO) bioavailability, although the underlying mechanism/s
were not explored,5 similar to effects observed with other amyloido-
genic proteins (light chain proteins in AL amyloidosis6 and b-amyloid7).
5 The effects of medin on human microvascular endothelial function are
not known. Our aim is to test the hypotheses that medin induces human
arteriole endothelial dysfunction through oxidative/nitrative stress and
reduced NO bioavailability, and that these effects are mediated via
actions on receptor for advanced glycation endproducts (RAGE).
10 2. Methods
2.1 Medin peptide
Medin was expressed using pOPINS-medin in Lemo 21 (DE3) cells8 and
purified as previously described.5 Expression was induced at OD600
1.0 with isopropyl-b-D-thiogalacto-pyranoside (1 mM) for 16 h at
15 20C. Cells were harvested by centrifugation and pellets resuspended in
6 M guanidine hydrochloride (GdmCl), 20 mM sodium phosphate,
20 mM NaCl, pH 8.0. Cells were homogenized and cell debris removed
by centrifugation. The supernatant was loaded onto a nickel-
nitrilotriacetic acid (Ni2þ–NTA) column, washed with 6 M GdmCl, pH 8
20 and pH 6, and eluted with 6 M GdmCl, pH 2. Fusion protein was buffer
exchanged into 20 mM Tris–Cl, 0.5 M NaCl, pH 7.4, and the His6–
SUMO tag removed with SUMO protease I. The protease and the tag
were removed using a Ni2þ–NTA column and the flow through contain-
ing medin buffer exchanged into phosphate buffered saline (PBS) and
25 flash-frozen. Medin was confirmed at >95% purity by sodium dodecyl
sulfate polyacrylamide gel electrophoresis and characterized by matrix-
assisted laser desorption and ionization mass spectrometry. Levels of
endotoxin were assessed to be <0.5 ng/ml using the Limulus Amebocyte
Lysate assay (Pierce, Dallas, TX).
30 2.2 Sources of human tissue
2.2.1Aortic tissue
We assessed tissue concentration of medin from aortic tissue (10
ascending, 2 descending) from 12 human subjects (61.25 ± 3.98 years,
range 39–81 years, four females, eight males). Tissue was obtained fol-
35 lowing informed consent from patients undergoing aortic surgery at
Liverpool Heart and Chest Hospital through Liverpool Biobank, with
approval granted by the Biobank Governance Board (Project number
15-06). The demographic information is provided in Table 1.
2.2.2Adipose arterioles
40 Research volunteers scheduled to undergo elective clinically indicated
abdominal surgery (inguinal or umbilical herniorrhaphy) and who were
not known to have vascular disease or diabetes provided written,
informed consent for subcutaneous adipose tissue donation (N= 35,
60.9 ± 2.3 years old, 1 female, 34 males by self-reported gender). The
45 study was approved and under the supervision of the Phoenix Veterans
Affairs Institutional Review Board (Migrino 001/004/1041).
2.2.3 Leptomeningeal arterioles
Leptomeningeal tissue were collected from cadavers following rapid
autopsy (post-mortem interval 2.90 ± 0.2 h, median 2.87 h), who prior to
50 death provided informed consent for brain donation post-mortem
under the Brain and Body Donation program [www.brainandbodydona
tionprogram.org (18 July 2017)].9 The donation program operations
have been approved by the Banner Sun Health Research Institute
Institutional Review Board. Tissues were immediately placed in sterile 4-
55(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (4C,
pH 7.4). Demographic information on brain donors were as follows:
N= 13, 88.1 ± 3.5 years old, four females, nine males. Neuropathologic
diagnoses were as follows: Alzheimer’s disease (AD) 4, vascular demen-
tia 1, Parkinson’s disease 4, mild cognitive impairment 2, and cognitively
60normal (age-consistent neuropathology only) 4. Additional details on
demographic information on the brain donors are in Supplementary
material online, Table S1.
All of the methods and procedures used conform to the principles
outlined in the Declaration of Helsinki.
652.3 Determination of tissue medin content
Human aortic tissue was homogenized in PBS at 10% w/v (100 mg of wet
tissue in 1 ml of PBS) using a MiniLys (Bertini Instruments, France). We
performed a 40-times dilution of the patient samples (10% homogenate,
followed by a 4-times sample dilution) to get the samples within the
70range of the standards 0–0.4lM and then calculated the values back up
to reflect the dilution process. Homogenized aorta samples and control
medin at 0.1, 0.2, and 0.4 mM were mixed 1:1 with Novex tricine SDS
sample buffer and heated to 70C for 5 min. Samples were then loaded
onto a 10–20% Novex tricine protein gel and subjected to electrophore-
75sis in Novex tricine SDS running buffer according to the manufactures
instructions (all Novex products sourced from Thermo Fisher Scientific,
UK). Proteins were transferred to nitrocellulose (Protran 2 mm,
Amersham GE Healthcare UK Ltd) for 1 h at 100 V. Western blots were
blocked in 5% v/v donkey serum (EMD Millipore, UK) in PBS at room
80temperature with gentle shaking for 1 h. The blots were probed with
medin antibody (custom antibody from GenicBio Hong Kong) at 1:1000
in PBS overnight at 4C. Blots were thoroughly washed with PBSþ 1%
Tween 20 (PBST) and then incubated with a 1:10 000 dilution of the sec-
ondary antibody, horseradish peroxidase conjugated donkey anti-rabbit
85(GE Healthcare, UK) for 1 h at room temperature. The blots were
washed again in PBST prior to chemiluminescent visualization using ELC
(EMD Millipore, UK).
The blots were analyzed using the gel analyzer tools in ImageJ
(National Institutes of Health, Bethesda, MD). A standard curve was
90plotted using the control medin samples and this was used to calculate
the amount of medin in each of the tissue samples. No protein control
for loading correction was assessed in the aortic tissue Western blot but
investigators were careful in using a consistent %weight/volume amount
of tissue for loading.
952.4 Human arteriole vasoreactivity
The details of the methodology have been previously reported.6,7,10,11
Adipose arterioles (161 ± 10 mm lumen diameter) were isolated and fol-
lowing cannulation, were pressurized to 60 mmHg, the estimated phys-
iologic pressure of similar sized arterioles in vivo. The vessels were
100preconstricted with increasing doses of endothelin-1 (10-9–10-4 M) until
60% of maximum diameter was reached. Using videomicroscopy, base-
line (control) dilator responses to acetylcholine (in successive doses of
10-9–10-4 M) to assess endothelium-dependent vasodilation were meas-
ured. Separate vessels were measured for dilator response to 10-7–
10510-4 M diethylenetriamine NONOate (DETA NONOate, Cayman
Chemical, Ann Arbor, MI) to assess endothelium-independent vasodila-
tion. This was followed by washout and then exposure (1 h) to medin
0.1, 1, and 5 mM (for adipose arterioles) and a second measurement of
2 R.Q. Migrino et al.
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dilator responses to acetylcholine or DETA NONOate. Additional adi-
pose arterioles were exposed to co-treatment of medin 5 mM, antioxi-
dant polyethylene glycol superoxide dismutase (PEG-SOD, 300 U/ml,
Sigma-Aldritch, St. Louis, MO), tetrahydrobiopterin (BH4, 100 mM,
5 an essential cofactor for endothelial nitric oxide synthase [eNOS]
function and maintenance of eNOS coupling,12,13 Schircks Laboratories,
Jona, Switzerland) or FPS-ZM1 (100 mM, a high-affinity RAGE-specific
inhibitor,14 Calbiochem, San Diego, CA). The maximum medin
dose selected in this study (5 mM) is at par with physiologic/pathologic
10 levels determined from our aortic tissue assays. Leptomeningeal
arterioles underwent similar assessment of dilator response to
acetylcholine at baseline, and after washout, post-treatment dilator
responses were measured following 1 h exposure to 5lM
medin ± 100lM FPS–ZM1 or 300 U/ml PEG-SOD.
15 2.5 Nitric oxide, peroxynitrite, and
superoxide production and measurement
of endothelial cell viability
The details of the methodology have previously been reported.10 Frozen
primary culture human umbilical vein endothelial cells (HUVECs, Lonza,
20 Walkersville, MD) at passage 1 isolated from pooled donors by the cor-
porate source were cultured and frozen down for future experiments as
per the source’s recommended protocols to form a working stock cul-
ture to draw from. Fresh cultures were seeded from these stocks and
cells (passages 5–8) were allowed to grow to full confluence before
25 treatment. Individual experimental treatments were in separate seeded
cultures from the frozen stocks. HUVECs seeded into 10 cm2 conical
culture tubes each with a glass cover slip at the bottom were treated
with vehicle control, medin 5 mM without or with PEG-SOD (300 U/ml),
FPS–ZM1 (100lM), or BH4 (100lM) for 1 h and medin 5 mM without
30 or with FPS–ZM1 (100 mM) for 20 h.
NO, superoxide, and peroxynitrite production were measured in
endothelial cells exposed to treatment for 1 and 20 h while endothelial
cell viability was measured following exposure to treatment for 20 h.
NO production was assessed by directly measuring NO head gas pro-
35 duction for cells treated for 20 h, and using 4,5-diaminofluorescein diace-
tate (DAF-2 DA) fluorescence for cells and arterioles treated for 1 h,
a well-validated fluorescence method to indirectly measure NO
production.15 Head gas was measured by piercing the seal of the conical
tube and using Sievers 280 nitric oxide Analyzer (General Electric
40Analytical Instruments, Waukesha, WI) and normalized to cell count.
For fluorescence microscopy measurements, endothelial cell-containing
glass coverslips were removed from the culture tubes, transferred into
12-well plates, washed, and then stained for 15 min with 5 mmol/l dihy-
droethidium (Thermo Fisher Scientific, Waltham, MA), a marker of
45superoxide production16 and 20 mmol/l coumarin boronate pinacolate
ester (Cayman Chemical, Ann Arbor, MI), a marker of peroxynitrite pro-
duction17 in HEPES buffer containing 10-4 M acetylcholine. NO was
assessed in HUVECs treated for 1 h by exposing cells to treatment
(vehicle, medin ± PEG-SOD or BH4 or FPS–ZM1) for 1 h, administration
50of acetylcholine (10-4 M) and staining with DAF-2 DA (10lM, Life
Technologies, Carlsbad, CA) 45 min into treatment exposure allowing
15 minutes of staining. Cells were then washed and fixed in 4% formalde-
hyde in PBS followed by cold methanol and mounted on glass slides for
imaging. Using EVOS FL Auto (Life Technologies), reacted dihydroethi-
55dium products were imaged using the RFP light cube (excitation 531/
40 nm; emission 593/40 nm), reacted coumarin boronate were imaged
using the DAPI light cube (excitation 357/44 nm; emission 447/60 nm)
and reacted DAF-2 DA were imaged using the GFP light cube (excitation
470/22 nm; emission 510/42 nm). Cell fluorescent signals were measured
60using ImageJ 1.49 analysis software and results expressed as values rela-
tive to control. For 20-h treated cells, the remaining cells from the cul-
ture tubes were lifted with trypsin into flow cytometry tubes, washed,
and resuspended in 10 nM calcein acetyoxymethyl (Life Technologies)
HEPES buffer containing 1.6 mM calcium for 15 min and then washed.
65This non-fluorescent compound is a marker of cell viability as presence
of intact cellular endogenous esterases will hydrolyze the compound
and release fluorescent calcein anion.18 Cellular fluorescent signals were
measured using Beckman-Coulter FC500 flow cytometer (Indianapolis,
IN) reading with excitation at 488 nm on the FL-1 channel. Results are
70expressed as values relative to control. In separate experiments,
HUVECs were treated for 20 h with vehicle, medin 5lM without or
with a,b,c,d-tetrakis(4-N-methylpyridyl) porphine (FeTMPyP, 50, 100,
and 200lM), a peroxynitrite decomposition catalyst,19 and cell viability
was assessed using calcein acetyoxymethyl fluorescence as described.
..............................................................................................................................................................................................................................
Table 1 Demographic information on sources of aortic tissue
Participant Age
(years)
Gender Aortic
diameter (cm)
Medin tissue
concentration (mM)
Cardiovascular risk factors/cardiac comorbidities
003 65 Male 5 12.12 Ex-smoker
004 48 Male 5.3 0
005 81 Female 5 7.8
006 48 Male 7 0 CAD, aortic valve replacement, hyperlipidemia, ex-smoker, stroke
007 51 Female 5.5 0
014 67 Female 5.1 8.4
015 65 Male 7 12 Aortic valve replacement, diabetes, hyperlipidemia, ex-smoker
016 77 Female 5.5 0 Heart failure, ex-smoker
017 77 Male 4.5 9.12 Ex-smoker
018 39 Male 5 0.92
019 68 Male N/A 13.72
020 49 Male 5.5 0 Aortic valve replacement
CAD, coronary artery disease; N/A, data not available.
Endothelial dysfunction induced by medin 3
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Adipose arterioles were exposed to 1 h treatment with vehicle con-
trol, medin 5lM ± PEG–SOD (300 U/ml) or FPS–ZM1 (100lM) and
NO was measured using DAF-2 DA staining while superoxide was meas-
ured using dihydroethidium staining similar to methods described above.
5 2.6 Endothelial cell proliferation and
migration assay
To assess the effect of medin on cellular proliferation, HUVECs were
plated in a 96-well plate at 8000 cells per well. After 24 h, cells were
treated with medin 5lM or vehicle and proliferation assay was per-
10 formed on cells treated on day 0 and 2 days following treatment using
Alamar Blue Assay (Thermo Fisher Scientific) modified from established
protocol.20 To perform the proliferation assay, media was removed
from the well plate and the samples were washed three times with
DPBS. The Alamar Blue solution was prepared in warmed culture media
15 at concentration of 10% (v/v) and then added to each well followed by
incubation for 4 h. Afterwards, fluorescence intensity was measured
using a fluorescent plate reader (FLUOstar Omega, BMG LabTech,
Ortenberg, Germany) at 544–590 nm wavelength.
A scratch-wound assay, modified from established protocol,21 was uti-
20 lized to analyze the effect of medin on endothelial cell migration. HUVECs
were plated in 24-well plate and incubated until 90% confluent. Later, a
pipette tip (20ll) was used to perform a straight scratch in the well. The
wells were next washed with DPBS and replaced with cell culture media
as a control or media containing medin 5lM. The 24 well-plate was placed
25 into a microscope incubator and imaged for 8 h overnight. Next, each
time point was analyzed by making 10 distance measurements between
the scratch. Distance migrated were quantified in ImageJ 1.49 analysis
software.
2.7 Pro-inflammatory signaling assays
30 The methodology for detecting gene and protein expression has been
previously reported.10 Quantitative polymerase chain reaction was used
to measure gene expression. HUVECs (passages 4–8) in LONZA EGM-
2 endothelial cell growth media were exposed to 20 h of vehicle control,
medin 1 or 5 mM, without or with co-treatment of either FPS-ZM1
35 (100 mM) or RO106-9920 (1, 10, or 100 mM, Tocris Biosciences, Bristol,
UK), a small molecule inhibitor of nuclear factor kappa-light-chain-
enhancer of activated B cells (NFjB)-dependent cytokine expression.22
After cell lysis, RNA was extracted and converted to cDNA using
Aurum Total RNA Mini Kit and iScript cDNA synthesis kit (Bio-Rad
40 Laboratories, Hercules, CA). Primers for inflammatory cytokines
interleukin-6 (IL-6) and interleukin-8 (IL-8) were purchased from
Integrated DNA Technologies and polymerization signal was measured
using SybrGreen on the Thermal Cycler CFX96 Real-Time System (Bio-
Rad Laboratories, Coralville, IA) with b-actin serving as reference gene
45 for normalization. In separate experiments, HUVECs were treated for
20 h with vehicle control, medin 5lM without or with either PEG-SOD
(300 U/ml) or FeTMPyP (200lM) and IL-6 and IL-8 gene expression
were measured using similar methods.
The conditioned cell media from above-treated HUVECs were col-
50 lected for measurement of IL-6 and IL-8 protein and stored at -80C
until time of enzyme linked immunosorbent assay (ELISA). Conditioned
media samples were thawed on ice and assayed either diluted 1:10 for
IL-8 or assayed whole for IL-6 ELISA to keep values within range of the
kit standards. Samples were assayed in duplicate as per instructions of
55 the appropriate Human IL-6 or Human IL-8 Quantikine ELISA kit (R&D
Systems, Minneapolis, MN).
2.8 Western blot assay
We measured total eNOS, phosphorylated eNOS (both serine 1177
and threonine 495) and computed phosphorylated eNOS:total eNOS
60ratio in HUVECs treated for 1 h with vehicle control and medin
5lM± FPS–ZM1 (100lM). In separate cells, we assessed whether med-
in’s pro-inflammatory effect is through NFjB-mediated cytokine produc-
tion, HUVECs were exposed for 5 h to vehicle control, medin 1 or 5 mM
without or with FPS–ZM1 (100 mM). Cells were lysed in complete radio-
65immunoprecipitation assay-based lysis buffer with phosphatase inhibitor
cocktail 2 and protease inhibitor (Sigma-Aldritch). 30 mg of protein
(determined by Bradford assay) was loaded for electrophoresis in pre-
cast MiniProtean TGX 4–20% gel (Bio-Rad Laboratories). Proteins were
transferred to polyvinylidene fluoride low fluorescence membrane for
70western blot at 100 V for 50 min. Antibodies against total eNOS (Sigma-
Aldritch), phosphorylated eNOS (Cell Signaling, Danver, MA), phos-
phorylated NFjB (Cell Signaling) at 1:500, 1:1000, and 1:1000 dilution,
respectively, were used and all membranes blocked a second time
before developing via 680 RD or 800 CW infrared fluorescent conju-
75gated goat secondary antibody (Li-COR Biosciences, Lincoln, NE) 1 to
15 000 dilution. Fluorescent bands in the infrared range were detected
using Li-COR Odyssey CLx imaging system. Signal was measured using
Image Studio 4.0 (Li-COR) normalized to b-actin and results are
expressed as values relative to control.
802.9 Data and statistical analyses
Data are expressed as mean ± standard error of means with significant
P-value (two-sided) set at P< 0.05. Arteriole dilator responses (response
to acetylcholine or DETA-NONOate) were assessed by comparing
post-treatment response with baseline control response using 2-way
85repeated measures analysis of variance (ANOVA) with pairwise post-
hoc analysis using Holm-Sidak method, while comparison between two
treatment responses were analyzed using 2-way ANOVA with pairwise
post-hoc analysis using Holm-Sidak method. Acetylcholine half-maximal
effective concentration (EC50, estimated dose that produces dilation
90to 50% of maximum dilation) was derived using nonlinear regression
with a variable slope (four parameters) and least squares ordinary fit
(GraphPad Prism 5.0, GraphPad software, La Jolla, CA) similar to our
previous methods6,10 and compared between baseline and treatment
response using paired Student t-test. For endothelial cell experiments,
95each data point (N) is a replicate that represents a separate independent
HUVEC batch. For non-normally distributed data, natural log (Ln) trans-
formation was first performed and ANOVA performed using normally
distributed Ln transformed data. For endothelial cell assays, group treat-
ment analyses were assessed using one-way repeated-measures analysis
100of variance (ANOVA) with post-hoc testing using Holm–Sidak pairwise
comparison for normally distributed data. For datasets with treatment
sample sizes that are not equal and data that are not normally distributed,
one way ANOVA on ranks was done and Dunn’s post hoc pairwise
comparison testing performed. Paired comparisons that are not normally
105distributed were analyzed using Wilcoxon signed rank test. Statistical
analyses were performed using Sigmastat 3.5 (Systat, San Jose, CA).
3. Results
Monomeric medin tissue concentration was determined from the
aortic tissue of 12 donor participants. The range was 0–75lg/g wet
110tissue (29.1 ± 8.9lg/g). Assuming an aortic tissue density of 1 g/ml,23
this corresponds to 0–13.72lM (mean 5.34, standard deviation 5.66,
4 R.Q. Migrino et al.
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median 4.36, interquartile range 4.36–9.84lM) (Figure 1A and B).
This physiologic dose range was used for our arteriole and endothelial
cell experiments. There was significant correlation between aortic
tissue medin content and age (R= 0.592, P= 0.04). Subjects who were
5 55 years old or older had significantly higher aortic medin than those
<55 years old.
Medin dose-dependently impaired peripheral adipose arteriole dilator
response to acetylcholine signifying impairment of endothelial function
(change vs. baseline control, medin 0.1, 1, and 5 mM: þ4.2 ± 3.1,
10 -23.1 ± 5.3, -45.2 ± 5.1%, respectively, Figure 2A–C). Acetylcholine LogM
EC50 was significantly higher (less negative) for arterioles treated with
medin 1lM (-5.87 ± 0.44 vs. -6.88 ± 0.17 control, P= 0.03) and 5lM
(-4.6 ± 0.32 vs. -7.07 ± 0.21 control, P< 0.001), but not 0.1lM (control
-7.4 ± 0.69, medin 0.1lM -7.82 ± 0.42). There was no significant reduc-
15 tion in dilator response to increasing doses of DETA NONOate, signify-
ing lack of effect on endothelium-independent function (Figure 2D).
DETA NONOate LogM EC50 for medin 5lM (-5.76 ± 0.31) was not
significantly different vs. control (-5.78 ± 0.0.28). The results were similar
in central leptomeningeal arterioles with medin-induced reduction in
20 dilator response to acetylcholine (-34.8 ± 6.5% vs. control) (Figure 2E).
Acetylcholine LogM EC50 was significantly higher for leptomeningeal
arterioles treated with medin 5lM vs. controls (-4.9 ± 0.8 vs. -6.7 ± 0.8,
P< 0.001).
Adipose arterioles exposed for 1 h to medin 5lM showed reduced
25NO and increased superoxide and peroxynitrite (Figure 2F–H). Similar
results were seen in HUVECs for NO and superoxide, however, the dif-
ference in peroxynitrite production between control and medin-treated
cells did not reach statistical significance following 1 h exposure, unlike
results following 20-h exposure (see results below).
30To assess the role of oxidative stress in causing endothelial dysfunc-
tion, adipose and leptomeningeal arterioles were co-treated with antiox-
idant PEG–SOD and medin. PEG–SOD restored arteriole dilator
response to acetylcholine (Figure 3A–D). PEG-SOD also restored NO
production and reduced superoxide production in endothelial cells
35treated with medin (Figure 3E–F).
To assess whether medin’s effect on reducing endothelial cell NO
and increasing superoxide is related to eNOS uncoupling, we measured
phosphorylated and total eNOS. Endothelial cells treated with medin
for 1 h did not show any difference with control in phosphorylated
40eNOS (serine 177 and threonine 495), total eNOS and phosphorylated
eNOS/total eNOS ratios (Supplementary material online, Figure S1A–H).
Adipose arterioles exposed to 1 h of medin plus essential NO synthase
co-factor BH4 restored dilator response to acetylcholine compared
with exposure to medin alone (Supplementary material online,
45Figure S1I). In addition, co-treatment for 1 h with medin and BH4
restored NO and reduced superoxide production in endothelial cells
when compared to medin treatment alone (Supplementary material
online, Figure S1J-K); no group differences were noted in peroxynitrite
production following 1 h treatment (Supplementary material online,
50Figure S1L).
In order to assess the role of RAGE in mediating the vascular effects
of medin, adipose arterioles were exposed to medin co-treated with
FPS–ZM1 (100 mM), a multimodal, high affinity and specific inhibitor of
RAGE.14 Arteriole dilator response was compared between arterioles
55treated with medin and with medin co-treated with RAGE inhibitor
FPS–ZM1. FPS–ZM1 restored dilator response to acetylcholine signifying
preservation of endothelial function in both adipose and leptomeningeal
arterioles (Figure 4A–D). There was a trend toward restoration of NO
production with FPS–ZM1 co-treatment (Figure 4E) that did not reach
60statistical significance on pre-specified pairwise post-hoc analysis follow-
ing repeated measures one way analysis of variance. However, paired
t-test analysis of arteriole NO production of medin vs. medinþ FPS–
ZM1 treatment showed significant difference (relative to control:
0.56 ± 0.9 vs. 0.89 ± 0.19 respectively, N= 7, P= 0.04). Furthermore,
65HUVECs treated for 1 h with medinþ FPS–ZM1 showed significantly
higher NO compared with medin-treated alone (signal relative to
vehicle-control: 1.0 ± 0, medin 5lM: 0.63 ± 0.05, medinþ FPS–
ZM1 100lM: 0.94 ± 0.14, P< 0.05 medin vs. C, P< 0.05 medin vs.
medinþ FPS–ZM1, n= 10), similar to results obtained with 20 h expo-
70sure (see results below). FPS–ZM1 co-treatment resulted in reduced
superoxide and peroxynitrite production in adipose arterioles following
1-h exposure (Figure 4F and G). FPS–ZM1 co-treatment or FPS-ZM1
alone did not change levels of phosphorylated eNOS (both serine 177
and threonine 495) or phosphorylated eNOS/total eNOS ratio
75(Supplementary material online, Figure S2A–H).
We also assessed the effects of medin on endothelial cell viability and
oxidative stress following 20-h exposure. There was dose-dependent
reduction in NO and increase in peroxynitrite (Figure 5A and C); medin
also increased superoxide production and reduced cell viability (Figure
805B and D). Co-treatment of medin with peroxynitrite decomposition
Figure 1 Aortic tissue medin. (A) Western blot using anti-human
medin antibody from varying doses of recombinant medin (left side of
panel) and from representative donor human aortic tissues (right side of
panel). This shows variable protein expression of monomeric medin
among various subjects with subjects’ ages shown at the bottom of the
figure. Note that aortic tissue loading was diluted to get the samples
within the range of the standards as detailed in Methods section. (B)
Comparison of aortic tissue medin concentration by age show
increased medin content in the aorta of subjects >_55 years old vs.
younger, suggesting age-related differences in medin accumulation in
aortic tissue (N= 5, age <55, N= 7, age >_55). *P< 0.05.
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.catalyst FeTMPyP (200lM) restored endothelial cell viability (Figure 5E).
Medin also caused reduced endothelial cell proliferation and reduction
in endothelial cell migration speed (Figure 5F and G).
Medin exposure for 20 h also caused increased gene and protein
5 expression of IL-6 and IL-8 in HUVECs (Figure 6A–D). There was a dose-
dependent increase in endothelial cell phospho–NFjB following 5 h of
exposure to medin (Figure 6E and F). Additional replicates were per-
formed to confirm the effects of medin on gene expression of IL-6 and
IL-8, and results were consistent in showing significant increase in IL-6
10 (relative to control: control 1 ± 0, medin 5lM 22.8 ± 4.7, N= 33,
P< 0.001) and IL-8 (relative to control: control 1 ± 0, medin 5lM
6519.4 ± 2413, N= 34, P< 0.001) (paired Wilcoxon signed rank test).
The increase in IL-6 and IL-8 induced by medin is likely related to
increased activation of NFjB as co-treatment with RO106-9920, an
15inhibitor of NFjB-dependent cytokine expression,22 reversed medin’s
effect on stimulating gene and protein expression of IL-6 and IL-8 (Figure
6G–J). Co-treatment of medin with either PEG-SOD or peroxynitrite
catalyst FeTMPyP did not reverse the increased IL-6 and IL-8 gene
expressions induced by medin in HUVECs (Supplementary material
20online, Figure S3).
Co-treatment of medin with FPS-ZM1 also restored 20 h endothelial
cell NO production and cell viability while reversing medin-induced
Figure 2 Effects of medin on human arteriole vasoreactivity and oxidative and nitrative stress. (A–C) Shows dilator response to acetylcholine in human
adipose arterioles exposed to increasing doses of medin for 1 h. There was dose-dependent reduction in dilator response to acetylcholine in medin-treated
arterioles signifying endothelium-dependent vasodilation. (D) Shows dilator response to NO donor DETA–NONOate in adipose arterioles exposed to
medin 5lM for 1 h. There was no significant change in dilator response suggesting medin does not impair endothelium-independent vasodilation. (E) Shows
that similar to response in adipose arterioles, medin-treated leptomeningeal arterioles show endothelial dysfunction with impaired dilator response to ace-
tylcholine. To assess the bases of observed endothelial function in human arterioles treated with medin, NO, superoxide, and peroxynitrite levels were
measured in adipose arterioles (F–H) and endothelial cells (I–K) treated with medin for 1 h. In both adipose arterioles and endothelial cell cultures, there was
reduction in NO and increase in superoxide production signifying medin-induced oxidative stress and reduced NO bioavailability. There was significant
reduction in peroxynitrite in adipose arterioles but not in endothelial cells with 1 h treatment. A N= 3, B N= 14, C N= 23, D N= 5, E N= 13, F N= 7 each, G
N= 9 each, H: N= 9 each, I: N= 8 each, J: N= 17 each, K N= 13 each; A–E 2-way repeated measures ANOVA with post-hoc pairwise Holm–Sidak test, F–K
paired t-test; *P< 0.05, **P< 0.01, ***P< 0.001 control vs. treatment group.
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increase in peroxynitrite production (Figure 7A–C). FPS–ZM1 co-treatment
also prevented phosphorylation of NFjB by medin as well as the increase
in gene and protein expression of IL-6 and IL-8 (Figure 7D–I).
4. Discussion
5 The study presents the following novel findings. First, medin induced
human arteriole and endothelial cell dysfunction likely through increased
oxidative and nitrative stress. Second, medin caused profound pro-
inflammatory signaling effect on endothelial cells mediated through acti-
vation of NFjB. Third, these adverse effects appear to be mediated via
10 RAGE. These findings demonstrate a new mechanism of injury on human
microvessels induced by medin that could be relevant in aging-related
vascular pathology.
4.1 Endothelial dysfunction induced by
medin
15Despite reports suggesting that medin is a ubiquitous human amyloi-
dogenic protein, being present in almost 100% of Caucasian subjects
studied over 50 years of age,2,24 little is known about medin’s patho-
physiologic effects. Consistent with previous reports demonstrating
increased arterial medin content with advanced age,1–4 we also show
20significant positive correlation between age and medin content in
aortic tissue, with significantly increased medin in subjects >_55 years
old vs. younger. Because previously published reports1–4 on medin
content in human vessels plus our current study still represent <100
total subjects studied, it is imperative that the epidemiology of
25medin vascular deposition be studied in larger subsets of patients to
confirm findings of high prevalence with aging in a large population.
Figure 3 Restoration of medin-induced endothelial dysfunction by antioxidant PEG–SOD. (A, C) Show no significant change in dilator response compared
with control in adipose and leptomeningeal arterioles treated with medin and antioxidant polyethylene glycol superoxide dismutase (PEG–SOD, 300 U/ml),
in contrast to Figure 2C and E. (B, D) Represent the difference in dilator response to acetylcholine following treatment and dilator response to acetylcholine
at baseline (control). These show that medin treatment (5lM) resulted in reduction of dilator response to acetylcholine in both adipose and leptomeningeal
arterioles that was not seen when medin was co-treated PEG–SOD, signifying restoration of endothelium-dependent vasodilation by PEG–SOD. (E–F)
Shows that co-treatment of medin 5lM with PEG–SOD (300 U/ml) for 1 h restores NO and reduces superoxide production. A:N= 5 each, B: medin
N= 20, medinþ PEG–SOD N= 5, C: N= 5 each, D: medin N= 13, medinþ PEGSOD N= 5, E N= 8 each and F N= 11 each. A, C were analyzed using 2-way
repeated measures ANOVA; B, D were analyzed using 2-way ANOVA with post-hoc Holm–Sidak pairwise test; E, F were analyzed using one-way repeated
ANOVA with post-hoc Holm–Sidak pairwise test; *P< 0.05, **P< 0.01, ***P< 0.01 (in B, D control vs. treated group, in E, F groups in bracket).
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..Our results show that medin induces profound endothelial dysfunc-
tion in human peripheral adipose and central leptomeningeal arterioles
while reducing endothelial cell viability, migration and proliferation. This
is likely due to induction of oxidative and nitrative stress (increased
5 superoxide and peroxynitrite) leading to decreased NO bioavailability,
because co-treatment with superoxide scavenger PEG–SOD restored
endothelial function, reduced superoxide, and increased NO produc-
tion. One possible mechanism underlying medin’s oxidative stress effects
may be due to eNOS uncoupling since our data showed no change in
10 phospho–eNOS/eNOS ratio with medin treatment (suggesting diver-
sion of eNOS activity from NO to superoxide production) and restora-
tion of endothelial function, NO production with reduced superoxide
following co-treatment with BH4, a nitric oxide synthase co-factor that
promotes eNOS coupling. Because endothelial dysfunction is an early
15and key abnormality that underlies aging-related arterial diseases includ-
ing essential hypertension and atherosclerosis,25 our observations sug-
gest a potential novel mechanism of vascular injury. Our results show
that medin does not affect arteriole dilator response to DETA–
NONOate, an NO donor, suggesting that medin does not affect down-
20stream signaling of NO through guanylate cyclase and cyclic guanosine
monophosphate (cGMP) to produce vasodilation.
Our results show reduced endothelial cell viability following exposure
to medin in the setting of increased superoxide and peroxynitrite pro-
duction. NO and superoxide react and form as primary intermediate
Figure 4 Restoration of medin-induced endothelial dysfunction by RAGE inhibitor. Co-treatment with medin and RAGE inhibitor FPS–ZM1 (100lM) in
adipose (A) or leptomeningeal (C) arterioles did not result in impaired dilation to acetylcholine compared with control. The change in dilator response from
baseline control was significantly different between vessels treated with medin vs. medinþ FPS–ZM1 (B, D) showing that FPS–ZM1 restored dilator
response of arterioles exposed to medin. (E) Co-treatment with FPS–ZM1 showed a trend, but not a statistically significant difference in NO production in
adipose arterioles treated with medin by pairwise post-hoc analysis following one way repeat measures ANOVA. However, paired t-test of NO production
of medin vs. medinþ FPS–ZM1 treatment showed significant difference (P= 0.04). (F, G) Shows that co-treatment of FPS–ZM1 with medin reduced adipose
arteriole superoxide and peroxynitrite production. A medin N= 23, medinþ FPS–ZM1; N= 5, B: medin N= 13, medinþ FPS–ZM1 N= 5, C: N= 7 each, D,
E: N= 9 each; A, C: 2-way repeated measures ANOVA with post-hoc pairwise Holm-Sidak test; B, D: 2-way ANOVA with post-hoc pairwise Holm–Sidak
test; E-G: 1-way repeated measures ANOVA with post-hoc pairwise Holm–Sidak test; *P< 0.05, **P< 0.01, ***P< 0.001 (in B, D control vs. treated group,
in E–G groups in bracket).
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..the potent oxidant peroxynitrite.17 Peroxynitrite is a potent mediator of
cellular damage in a wide range of conditions including cardiovascular
disease.26 Our results demonstrated that FeTMPyP, a peroxynitrite
decomposition catalyst, restored endothelial cell viability in the setting of
5 medin exposure, suggesting that medin’s effect on cell viability is medi-
ated via peroxynitrite.
Using a high-affinity specific inhibitor, we demonstrated that the effects
of medin are mediated via RAGE. Another amyloidogenic peptide, b-
amyloid, uses the same receptor to mediate perturbations in cerebral
10 vessels, neurons and microglia in AD.27 Indeed, we previously showed
that similar to medin, Ab42 induces endothelial dysfunction in
leptomeningeal and adipose arterioles through reduced NO bioavail-
ability and induction of oxidative and nitrative stress.7,11 Since both
medin and Ab were shown to be present in cerebral vessels especially
15with advanced age, it is important in future studies to fully define contri-
buting effects on vascular function and possible interactions by both amy-
loid proteins.
4.2 Medin and proinflammatory vascular
signaling
20Our findings show that medin also induces pro-inflammatory signaling
in endothelial cells with increased gene and protein expression of IL-6
Figure 5 Adverse effects of medin on endothelial cell viability and function. In A–E, HUVECs were treated with medin for 20 h. There was reduction in
NO, increase in superoxide and peroxynitrite production (A–C). There was reduced cell viability (D). In separate independent experiments, co-treatment
with peroxynitrite catalyst FeTMPyP restored viability in cells treated with medin (E). These suggest that medin’s adverse effect on endothelial cell viability is
mediated by oxidative/nitrative stress. Medin also caused reduction in endothelial cell proliferation over 2 days (F) and reduced endothelial cell migration in
24 h following scratch wound assay (G). Note that in G, connecting lines represent data from paired independent experiments to facilitate data representa-
tion (cells were separately treated with either vehicle or medin). A: N= 8 each, B: N= 23 each, C: N= 8 each, D: N= 16 each, E–G: N= 5 each; A, C, E and F
were analyzed using repeated measures ANOVA with post-hoc pairwise Holm–Sidak, B, D and G were analyzed using paired t-test; *P< 0.05, ***P< 0.001,
þþþP< 0.001 vs. FeTMPyP 200lM, ###P< 0.001 vs. control, $$$P< 0.001 vs. medin 5lMþ FeTMPyP 200lM.
Endothelial dysfunction induced by medin 9
Figure 6 Medin induces pro-inflammatory cytokine production in endothelial cells. In A–D, endothelial cells were exposed for 20 h to increasing doses of
medin. There was increased gene expression of interleukin (IL)-6 and IL-8 following exposure to medin 1 and 5lM and corresponding increase in IL-6 and
IL-8 protein expression with medin 5lM dose showing that medin induces pro-inflammatory signaling in endothelial cells. E–F Shows that medin increased
levels of phosphorylated NFjB, a protein complex known to control transcription of cytokine production. Co-treatment with NFjB inhibitor RO106-9920
prevented medin-induced increases in IL-6 and IL-8 gene (G, H) and protein (I, J) expression, suggesting that the proinflammatory effects of medin is through
activation of NFjB. Note that to facilitate data representation, logarithmic scale was used in A-D and H. A: N= 5 each, B: N= 7 each, C: C—N= 21, medin
1—N= 5, medin 5—N= 21; D: C—N= 17, medin 1—N= 7, medin 5—N= 15, E: C—N= 11, medin 0.1—N= 3, medin 1—N= 5, medin 5—N= 11; A–B, E,
G–J were analyzed using repeated measures ANOVA with post-hoc pairwise Holm-Sidak, C–D were analyzed using one-way ANOVA with post-hoc pair-
wise analyses by Dunn’s method; *P< 0.05, **P< 0.01, ***P< 0.001.
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and IL-8. This is likely mediated through NFjB signaling as supported
by the increase in phospho–NFjB and the reversal of pro-
inflammatory signaling by NFjB inhibitor RO106-9920. Interleukin-6
and IL-8 function as chemoattractants to neutrophils, basophils, and
5 lymphocytes28 and are also upregulated in the presence of other car-
diovascular risk factors such as hyperlipidemia, smoking and dia-
betes.29 In addition, studies suggest that IL-8 may also promote
angiogenesis.30 A potential implication is that the presence of medin
could possibly amplify pro-inflammatory and oxidative stress signaling
10 induced by other risk factors. Medin’s stimulatory effects on gene
expression of IL-6 and IL-8 were not reversed by co-treatment with
PEG–SOD or FeTMPyp at doses that reversed medin-induced reduc-
tion of endothelial cell viability, suggesting that medin’s pro-
inflammatory effect is independent of superoxide or peroxynitrite
15generation. Although peroxynitrite has been shown to activate NFjB-
dependent proinflammatory signaling in human polymorphonuclear
cells26,31,32 and monocytes,33 other investigators showed the oppo-
site effect in other types of cells,26,34 including endothelial cells,35 sug-
gesting that the relationship between peroxynitrite and NFjB
20signaling is complex and may be cell-type and condition dependent.
The effects on immune signaling with chronic exposure remains to be
studied, but if the pro-inflammatory response seen with acute exposure
is not muted, a state of prolonged vascular inflammation could be created
with potential implications for long-term atherosclerosis development.
25There is no prior study that we know of that showed pro-inflammatory
effects and reduced endothelial function following exposure to medin;
however, our findings are complementary to the work by Peng et al.3
showing that vascular smooth muscle cells exposed to medin increased
Figure 7 RAGE inhibitor protects viability of endothelial cells and prevents pro-inflammatory signaling following medin treatment. In A–C, co-treatment
for 20 h of RAGE inhibitor FPS-ZM1 (100lM) with medin restored endothelial cell viability, restored NO production and reduced peroxynitrite production
compared with medin treatment alone. D–E Shows that FPS–ZM1 co-treatment with medin also reduces phosphorylated NFjB levels, gene and protein
expression of interleukin (IL)-6 and IL-8. Note that to facilitate data representation, logarithmic scale was used in F, H–I. A, C-D and F–I: N= 5 each,
B: C—N= 22, medin—N= 22, medinþ FPS–ZM1—N= 5; A, C, D, F–I were analyzed using repeated measures ANOVA with post-hoc pairwise Holm–Sidak,
B was analyzed using 1-way ANOVA with post-hoc pairwise Holm–Sidak; *P< 0.05, **P< 0.01, ***P< 0.001.
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the production of matrix metalloproteinase-2, a protease that degrades
elastin and collagen leading to weakening of the vessel wall. The
same group observed that medin was present in the temporal arteries
of both elderly patients and patients with giant cell arteritis,4 with
5 the authors raising the question of the role of medin in arterial
inflammation.
4.3 Potential homology with other amyloid
proteins
Our results show very similar mechanisms of injury induced on human
10 microvessels by medin when compared to our previous studies on amy-
loidogenic light chain proteins6 and b-amyloid,7,11 despite having widely
varying amino acid sequences. The exact basis for this observation
remains unknown but other studies suggest a structural homology
shared by misfolded proteins. Kayed et al.36 showed that six amyloid pro-
15 teins with no sequence homology nevertheless showed similar cellular
cytotoxicity, and administration of antibody against soluble oligomers
culled from various amyloid proteins uniformly protected against cyto-
toxicity in all six amyloid species. Lashuel et al.37 showed using electron
microscopy that three amyloid proteins associated with Parkinson’s dis-
20 ease and Alzheimer’s disease with widely variant amino acid sequences
showed similar annular morphologic tertiary structure conformations
that are indistinguishable from each other, which they postulate may
underlie the common toxicity among these amyloid proteins. Our
group’s current and prior findings that medin, amyloid light chains and b-
25 amyloid show similar effects of endothelial dysfunction, oxidative and
nitrative stress are consistent with this body of work by other investiga-
tors. Another implication of this observation is that the multi-organ tox-
icity seen with many misfolded proteins may be mediated, at least in part,
by common effects on the microcirculation and that therapeutic
30 approaches to mitigate the deleterious effects on the microvasculature
may have general, not just protein- or disease-specific, utility.
4.4 Human microvascular model
Our findings also demonstrate similarity in degree and direction of
response to medin in peripheral subcutaneous adipose and central lep-
35 tomeningeal arterioles. This is similar to our results when we exposed
living subject adipose, cadaver adipose and leptomeningeal arterioles to
Ab4211 and when adipose arterioles and atrial coronary arterioles were
exposed to AL light chain proteins.6 This supports the contention that
more easily obtainable subcutaneous adipose arterioles could be accept-
40 able surrogates to study pathophysiologic responses in central (cerebro-
vascular or coronary) arterioles. This has potential translational
relevance in offering a new ex vivo human model for studying vascular
pathophysiology.
4.5 Limitations
45 This study has several important limitations. Our human ex vivo vascular
model and endothelial cell experiments only studied acute, and not
chronic, effects of medin exposure. It is not known whether chronic
exposure will lead to sustained vascular insult and this needs to be estab-
lished in future studies to better determine the link with human aging-
50 related vascular pathology. The study lacked in vivo confirmation and our
results should be confirmed in vivo with future animal experiments.
Despite this limitation, the results of our acute exposure experiments
remain salient by providing important foundational knowledge on poten-
tial mechanisms of action underlying medin vascular effects that would
55 be relevant starting points in studying in vivo pathophysiology and
mechanisms. Although it is intuitive to attribute, at least in part, the
reduction in endothelial cell proliferation following medin exposure to
medin’s effect in reducing cell viability based on prior work showing the
tight relationship between endothelial cell viability and proliferation,38
60the study did not specifically explore this relationship. Future studies
should look into whether medin’s effect is also due to dysregulation of
known signaling pathways regulating endothelial cell proliferation such as
expression of growth factors (e.g. vascular endothelial growth factor) or
MAPK signaling.39 Our results support the possible role of eNOS uncou-
65pling by medin in causing oxidative and nitrative stress, but future studies
need to determine if other sources of oxidative stress such as mitochon-
dria or nicotinamide adenine dinucleotide phosphate oxidase, among
others, may be affected by medin since a previous study demonstrated
multiple sources of superoxide production induced by another type of
70amyloidogenic protein (light chains in AL).6 Although we measured only
IL-6 and IL-8, in light of activation of NFjB, we anticipate, but did not ver-
ify, that other cytokines known to be upregulated by NFjB will also be
increased by medin. We limited our study on RAGE and did not formally
test whether other endothelial cell receptors known to mediate inflam-
75mation, such us toll-like receptors, are involved. The degree of medin’s
effect on inflammatory cytokine gene and protein expression in endo-
thelial cells is substantial. Our results showed 27 times increase in
IL-8 protein expression (control 1716 ± 398 vs. medin 5lM
47046 ± 10836 pg/mL, P< 0.01, Figure 6D). To put this in context, human
80umbilical veins exposed for 24 h to lipopolysaccharide (100 ng/ml), a
classic proinflammatory bacterial agent, increased IL-8 only 4-6 times.40
Our findings do not explain the discrepancy between the degrees of
gene and protein expression increases in IL-8. To investigate this inter-
esting observation, future follow-up studies should be performed to sys-
85tematically investigate potential causes including mRNA stability, rate of
mRNA decay and factors that may be affecting protein expression at the
post-transcriptional level. The gender composition of our sources of adi-
pose arterioles is not diversified despite our attempts to actively recruit
both male and female participants owing to the current makeup of the
90elective surgical population in our Veteran’s Affairs hospital. Although
there is a potential link between medin effects and vascular dysfunction
associated with aging, and our results show increased medin aortic con-
tent in subjects >55 years old vs. younger, we did not look at aging/sen-
escence markers in our vessels or endothelial cells to further explore
95these relationships, an area of future study. Although the investigators
were careful in using a consistent %weight/volume amount of tissue for
loading aortic tissue for western blot, the lack of measurement of a con-
trol protein to correct for loading could potentially overestimate or
underestimate actual medin tissue content.
1004.6 Conclusions
In conclusion, physiologic doses of medin induces RAGE-mediated
human peripheral and central arteriole endothelial dysfunction, with dys-
regulated endothelial cell NO bioavailability, oxidative and nitrative
stress leading to reduced endothelial cell viability and proinflammatory
105signaling via NFjB activation (proposed schema in Figure 8). This advan-
ces our understanding of the acute effects of medin in vascular function
and identifies a potential novel mechanism of vascular injury.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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